Insider · CIK 0002076862

Ghias Babar

Reports to the SEC for 1 company · DURHAM, NC

Transactions

Companies

Filings

CIK

0002076862

Forms 4 and 5

Insider transactions

4 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-17	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Chief Financial Officer	AAward	+122K sh	—	—	268,700
2025-12-17	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+355K sh	—	—	355,050
2025-07-24	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Chief Financial Officer	AAward	+147K sh	—	—	147,000
2025-07-24	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+305K sh	—	—	305,000

4505 EMPEROR BLVD. SUITE 200

DURHAM, NC, 27703